Animated Language Learning Ltd
Sector: Hospital • Location: Ireland
Source: EU Funding & Tenders Portal
Animated Language Learning is an Irish high growth company, driving forward a ground breaking innovative approach to the development and education of children with autism. The core team is led by Enda Dodd CEO, a Fortune 200 (Medical devices) New Product Development VP; and Valerie Dodd, head of product development, as well as a teacher/psychologist. Our two product development professionals, Cono
- Status
- Closed
- Sector
- Hospital, Commercial, Education
- Location
- Ireland
- Updated
- 22 Jul 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about Animated Language Learning Ltd
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | ended |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Animated Language Learning is an Irish high growth company, driving forward a ground breaking innovative approach to the development and education of children with autism. The core team is led by Enda Dodd CEO, a Fortune 200 (Medical devices) New Product Development VP; and Valerie Dodd, head of product development, as well as a teacher/psychologist. Our two product development professionals, Conor and Eoin Dodd, have emerged from Autism, thanks to the ALL approach. Our team benefits from inputs from global key opinion leaders across relevant clinical, technical, educational and commercial areas including the University of California and National University Ireland Galway (NUIG), Disney, Adobe, Microsoft and Google are also supporting our efforts. We are a global developer of language development tools for Autistic children (ASD) with our first commercial offering currently undergoing pilot studies in the US, UK, Canada, Ireland and Australia. Children diagnosed with autism fail to develop communication skills and face long term societal dependency and institutionalisation. The US centres for disease control (CDC) reports US Incident rate is approximately 1:68 births and further that European and Asian rates are similar . Annual costs associated with treating this condition in the US and UK alone across clinical, educational, custodial and lost earnings have been estimated to be $283 billion for a total ASD (autism) population of 4.5 million. Despite substantial differences in healthcare policies in the two countries, life time costs associated with the condition were similar. Multiple peer reviewed studies collated by the CDC indicate that ASD prevalence in Europe and Asia is commensurate with the US / UK study. We have developed a fundamentally different, life-changing and effective technology which is significantly lower cost, capable of unlocking the potential of those diagnosed with ASD so they can make a contribution to society instead of being a burden. |
Location
Country | Ireland |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Sector | Hospital, Commercial, Education |
Article published date | 2026-02-01 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hospital projects in Ireland
- Merrion Biopharma Research and Development Laboratories
- Cordis Corporation Manufacturing Plant, Cashel, Co Tipperary
- GE Healthcare Biopharmaceutical Campus, Cork County, Ireland
- AstraZeneca API Manufacturing Facility, Dublin, Ireland
- Turnkey Digital Health Platform Solution
- Protein Data for Precision Medicine
- UNIVERSITY OF LIMERICK
- GAA INVESTMENT PROGRAMME
